Real Life Data on OnabotulinumtoxinA for Treatment of Chronic Migraine in Pediatric Age

Background: The use of OnabotulinumtoxinA (OBT-A) for the treatment of chronic migraine (CM) in adults represents a therapy with the greatest efficacy and safety data. However, we have little evidence on the use of OBT-A in children or adolescents. The present study aims to describe the experience w...

Descripción completa

Detalles Bibliográficos
Autores principales: Papetti, Laura, Frattale, Ilaria, Ursitti, Fabiana, Sforza, Giorgia, Monte, Gabriele, Ferilli, Michela Ada Noris, Tarantino, Samuela, Proietti Checchi, Martina, Valeriani, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003637/
https://www.ncbi.nlm.nih.gov/pubmed/36902596
http://dx.doi.org/10.3390/jcm12051802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003637/
https://www.ncbi.nlm.nih.gov/pubmed/36902596
http://dx.doi.org/10.3390/jcm12051802

Ejemplares similares